肺ペスト(Pneumonic Plaque):治療薬開発パイプライン動向2018

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIPR2016511)
◆英語タイトル:Pneumonic Plaque-Pipeline Insights, 2018
◆発行会社/調査会社:DelveInsight
◆商品コード:DIPR2016511
◆発行日:2019年01月
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥135,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[肺ペスト(Pneumonic Plaque):治療薬開発パイプライン動向2018]についてメールでお問い合わせはこちら
※本調査レポートでは、世界における肺ペスト(Pneumonic Plaque)の治療薬開発パイプライン動向について調査・分析し、企業別開発中の治療薬、各臨床試験段階における製品リスト及び比較分析、薬剤候補のプロファイル、治療薬の評価、開発中止又は開発休止中の薬剤リスト等をお届けしています。また、肺ペスト(Pneumonic Plaque)治療薬開発に取り組んでいる企業情報も提供しています。

・肺ペスト(Pneumonic Plaque)の概要

・肺ペスト(Pneumonic Plaque)の治療薬パイプライン概要

・企業別開発中の肺ペスト(Pneumonic Plaque)治療薬

・後期治験段階の薬剤(Filed & Phase III):比較分析

・中期治験段階の薬剤(Phase II):比較分析

・初期治験段階の薬剤(Phase I & IND Filed):比較分析

・前臨床段階の薬剤:比較分析

・薬剤候補のプロファイル

・肺ペスト(Pneumonic Plaque)治療薬の評価
  - 単剤治療薬別評価
  - 併用治療薬別評価
  - 投与経路別評価
  - 分子種類別評価

・開発が中止された薬剤リスト

・開発休止中の薬剤リスト

・肺ペスト(Pneumonic Plaque)治療薬開発に取り組んでいる企業リスト

・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s, “ Pneumonic Plaque-Pipeline Insights, 2018”, report provides in depth insights on the pipeline drugs and their development activities around the Pneumonic Plaque. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Pneumonic Plaque. DelveInsight’s Report also assesses the Pneumonic Plaque therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.


Scope
• The report provides competitivepipeline landscape of Pneumonic Plaque
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Pneumonic Plaque pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Pneumonic Plaque and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


*** レポート目次(コンテンツ)***

Table of Contents
• Pneumonic Plaque Overview
• Pneumonic Plaque Pipeline Therapeutics
• Pneumonic Plaque Therapeutics under Development by Companies
• Pneumonic Plaque Filed and Phase III Products
• Comparative Analysis
• Pneumonic Plaque Phase II Products
• Comparative Analysis
• Pneumonic Plaque Phase I and IND Filed Products
• Comparative Analysis
• Pneumonic Plaque Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Pneumonic Plaque – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Pneumonic Plaque – Discontinued Products
• Pneumonic Plaque – Dormant Products
• Companies Involved in Therapeutics Development for Pneumonic Plaque
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Pneumonic Plaque, 2018
• Number of Products under Development by Companies
• Comparative Analysis by Filed and Phase III Products, 2018
• Comparative Analysis Phase II Products, 2018
• Comparative Analysis Phase I and IND Filed Products, 2018
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2018
• Drug Candidates Profiles
• Pneumonic Plaque Assessment by Monotherapy Products
• Pneumonic Plaque Assessment by Combination Products
• Pneumonic Plaque Assessment by Route of Administration
• Pneumonic Plaque Assessment by Stage and Route of Administration
• Pneumonic Plaque Assessment by Molecule Type
• Pneumonic Plaque Assessment by Stage and Molecule Type
• Pneumonic Plaque Therapeutics – Discontinued Products
• Pneumonic Plaque Therapeutics – Dormant Products
• Products under Development by Companies, 2018


List of Figures
• Number of Products under Development for Pneumonic Plaque, 2018
• Filed and Phase III Products, 2018
• Phase II Products, 2018
• Phase I and IND Filed Products, 2018
• Discovery and Pre-Clinical Stage Products, 2018
• Pneumonic Plaque Assessment by Monotherapy Products
• Pneumonic Plaque Assessment by Combination Products
• Pneumonic Plaque Assessment by Route of Administration
• Pneumonic Plaque Assessment by Stage and Route of Administration
• Pneumonic Plaque Assessment by Molecule Type
• Pneumonic Plaque Assessment by Stage and Molecule Type


*** レポートのキーワード ***

肺ペスト(Pneumonic Plaque)、治療薬、医薬品、薬剤、製薬企業、研究開発、治験、パイプライン

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • チェロギグバッグの世界市場:販売動向2017
    Notes:Sales, means the sales volume of Cello Gig Bags Revenue, means the sales value of Cello Gig Bags This report studies sales (consumption) of Cello Gig Bags in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, pric …
  • アルコールRTD飲料/高強度プレミックスの北米市場
    KEY FINDINGSThe North America alcoholic ready-to-drink (RTDs)/high strength premixes market is anticipated to grow at -0.16% (negative) CAGR during the forecast period 2017-2025. A rise in disposable income, changing lifestyle and growing demand for alcoholic drinks from the younger population is re …
  • 調味料、ドレッシング及びソース市場データ(~2017):マルタ
    Synopsis "Seasonings, Dressings & Sauces Market in Malta: Databook to 2017" is the result of Canadean’s extensive market research covering the Seasonings, Dressings & Sauces market in Malta. The report presents detailed historic and forecast data on the Seasonings, Dressings & Sauces consumption tre …
  • 非GMO食品の世界市場:販売動向2017
    Notes:Sales, means the sales volume of Non-GMO Foods Revenue, means the sales value of Non-GMO Foods This report studies sales (consumption) of Non-GMO Foods in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, …
  • ホーニング盤の世界市場
    Honing Machine Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany …
  • SCR脱硝触媒のトップ5メーカー分析(北米、欧州、アジア、南米、中東、アフリカ)
    This report studies SCR Denitrification Catalyst in Global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 SCR Denitrification Catalyst Players in each region, with sales, price, revenue and market share for top 5 manufacturer, c …
  • Hadoopの世界市場2015-2022
    According to Stratistics MRC, the global hadoop market is expected to grow at a CAGR of 53.7% over the forecast period 2015 to 2022. Increasing investments in data management, rising amount of structured and unstructured data, hasty growth in consumer data and rapidly increasing demand for big data …
  • 世界主要国におけるソルケタール市場2018-2023
    In 2017, the global Solketal (CAS 100-79-8) market size was xx million USD, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. This report studies Solketal (CAS 100-79-8) in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, …
  • MMC – South Paterson Hotel and Hospital – New Jerseyの建設プロジェクト概要
    World Market Intelligence's "MMC – South Paterson Hotel and Hospital – New Jersey - Construction Project Profile" is a crucial resource for industry executives and anyone looking to access key information about the MMC – South Paterson Hotel and Hospital – New Jersey construction project. World Mark …
  • 小麦グルテンの世界市場(市場規模、成長率、予測):Global Market for Wheat Gluten to 2017 – Market Size, Growth and Forecasts in Over 50 Countries
    This comprehensive publication enables readers the critical perspectives to be able to evaluate the world market for wheat gluten. The publication provides the market size, growth and forecasts at the global level as well as in different countries around the world. The market data covers the years 2 …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIPR2016511 )"肺ペスト(Pneumonic Plaque):治療薬開発パイプライン動向2018" (英文:Pneumonic Plaque-Pipeline Insights, 2018)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。